Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Dec
4
2018
Will PTAB SOP 2 Promote Uniformity Across The USPTO Foley & Lardner LLP
Dec
18
2018
Federal Circuit Says No OTDP Between Novartis Patents That Straddle URAA Foley & Lardner LLP
Jul
6
2023
IP Considerations in Protecting Autonomous Vehicle Software with Patents and Copyrights Foley & Lardner LLP
Feb
16
2019
New Estoppel Concern For Petitioners Raised in BTG v. Amneal Foley & Lardner LLP
Jul
25
2023
Would The Patent Eligibility Restoration Act Strike The Right Balance? Foley & Lardner LLP
Mar
13
2019
Court Dismisses Biosimilar Petitioner's IPR Appeal For Lack of Standing Foley & Lardner LLP
Sep
13
2023
Regulating Influencer Marketing: A Comparative Analysis of Laws Across the World Foley & Lardner LLP
May
30
2019
They Started It! Foley & Lardner LLP
Jun
4
2019
Federal Circuit Invalidates Vimovo Patents Questioning Possession Of Efficacy Under The Written Description Requirement Foley & Lardner LLP
Jun
18
2019
Why The TERM Act Is A Misguided Solution To A Different Problem Foley & Lardner LLP
Jul
23
2019
Australia Holds The Line On Patent Eligibility Of Diagnostic Methods Foley & Lardner LLP
Aug
6
2019
USPTO Proposes Fee Hikes And New Fees Foley & Lardner LLP
Apr
28
2016
Having A Bad Hair Day? The Federal Circuit Agrees That Method Of Cutting Hair Is Invalid Under 101 Foley & Lardner LLP
May
24
2016
Federal Circuit Affirms Finacea Gel Infringement Under Doctrine of Equivalents Foley & Lardner LLP
Mar
27
2024
Trademark Primer: Proactive Strategies for Avoiding Disputes and Consumer Confusion Foley & Lardner LLP
Jun
14
2016
Supreme Court Adopts More Flexible Standard For Enhanced Damages For Willful Infringement Foley & Lardner LLP
Apr
29
2024
Cancer Drugs: Strategies For Patenting Antibody-Drug Conjugate Inventions Foley & Lardner LLP
Jun
21
2016
Supreme Court Defers Certiorari Decision In Amgen Sandoz Biosimilar Patent Dance Dispute Foley & Lardner LLP
Jul
5
2016
Supreme Court Declines Sequenom Review Foley & Lardner LLP
Jul
21
2016
Could the Flying Car Finally Take Off? Foley & Lardner LLP
Apr
1
2020
Will The USPTO Extend Deadlines Under The CARES Act? Foley & Lardner LLP
Aug
9
2016
AbbVie Sues Amgen On 10 Of 100 Humira Patents Foley & Lardner LLP
Oct
20
2016
USPTO Makes It Easy To Review Patent Assignment Documents Foley & Lardner LLP
May
18
2020
A Rubric for Design Patent Claim Construction to a “Tee” Foley & Lardner LLP
Jun
1
2020
USPTO Extends, Modifies CARES Act Deadline Relief Foley & Lardner LLP
Nov
8
2016
PTAB Post-Grant Fees Slated To Increase Foley & Lardner LLP
Jul
13
2020
Exclusive License Can Raise Obviousness-Type Double Patenting Issues Foley & Lardner LLP
Dec
15
2016
Reduced Scope of Post-IPR Estoppel Imperils Litigation Stays Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins